The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...

Overall, Edwards enjoys a great deal of financial flexibility that would allow for more substantial acquisitions, if those opportunities were to arise. Edwards Lifesciences has come to dominate ...

Adjusted earnings per share came in at 59 cents, compared to analysts’ estimate of 55 cents. Transcatheter Aortic Valve ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy ...

CoreMedic announced that it picked up new funding in a Series B extension to support its transcatheter mitral valve repair ...

With new transcatheter options for the repair or replacement of tricuspid valves, the role and timing of repair — whether surgical or minimally invasive — is entering a time of transition.

The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It ...

“The MitraClip is a revolutionary device that allows mitral valve repair without surgery, offering new hope to patients who cannot undergo traditional open-heart procedures. It significantly ...